Monografias.com > Uncategorized
Descargar Imprimir Comentar Ver trabajos relacionados

Desarrollo embrionario del pelo (página 5)



Partes: 1, 2, 3, 4, 5

60. Lorenzo EM. Familial
study of hirsutism. J Clin Endocrinol

1970 31:556-564

61. Mahoudeau JA, Bardin
CW, Lipsett MB. The metabolic

clearance rate and origin
of plasma dihydrotestosterone in

man and its conversion to
the 5a-androstenediols. J
Clin

Invest 1971 50:1338-1344

62. Marugo M, Bernasconi D,
Meozzi M, Del Monte P, Zino V,

Primarolo P, Badaracco B.
The use of flutamide in the

management of hirsutism. J
Endocrinol Invest 1994 17:195-199

Revista de Endocrinología
Ginecológica y Reproductiva 17

63. Mathur RS, Moody LO,
Landgrebe S, Williamson HO. Plasma

a n d rogens and sex
hormone binding globulin in the

evaluation of hirsute
females. Fertil Steril 1981 35:29-35

64. Mauvais-Jarvis P.
Regulation of androgen receptor and 5-

reductase in the skin of
normal and hirsute women. Clin

Endocrinol Metab 1986
15:307-317

65. McKenna TJ, Miller RB,
Liddle GW. Plasma pregnenolone

and 17-OH pregnenolone in
patients with adrenal tumors,

ACTH excess, or idiopathic
hirsutism. J Clin Endocrinol

Metab 1977 44:231-236

66. Mehta A, Matwijiw I,
Taylor PJ, Salamon EA, Kredentser JV,

Faiman C. Should androgen
levels be measured in hirsute

women with normal
menstrual cycles? Int J Fertil 1992 37:354-357

67. Meikle AW, Odell WD.
Effect of short and long-term

dexamethasone on
3a-androstanediol glucuronide in hirsute

women. Fertil Steril 1986
46:227-231

68. Mowszowicz I,
Melanitou E, Doukani A, Wright F, Kuttenn F,

Mauvais-Jarvis P. Androgen
binding capacity and 5areductase

activity in pubic skin
fibroblasts from hirsute

patients. J Clin
Endocrinol Metab 1983 56:1209-1213

69. Müderris II, Bayram F,
Sahin Y, Kelestimur F, Tutus A, Ayata

D. The efficacy of 250
mg/day flutamide in the treatment of

patients with hirsutism.
Fertil Steril 1996 66:220-222

70. O"Brien RC, Cooper ME,
Murray RML, Seeman E, Thomas AK,

Jerums G. Comparison of
sequential cypro t e rone acetate/

e s t rogen vs.
spironolactone/oral contraceptive in the tre a t m e n t

of hirsutism. J Clin
Endocrinol Metab 1991 72:1008-1013

71. Oh HS, Smart RC. An
estrogen receptor pathway regulates

the telogen anagen hair
follicle transition and influences

epidermal cell
proliferation. Proc Natl Acad Sci USA 1996

93:12525-12530

72. Pang S, Wang M,
Jeffries S, Riddick L, Clark A, Estrada E.

Normal and elevated
3a-androstanediol glucuro n i d e

concentrations in women
with various causes of hirsutism

and its correlation with
degree of hirsutism and androgen

levels. J Clin Endocrinol
Metab 1992 75:243-48

73. Paoletti A, Cagnacci
A, Orru M, Ajossa S, Guerriero S, Melis

G. Treatment with
flutamide improves hyperinsulinemia in

women with idiopathic
hirsutism. Fertil Steril 1999 72(3):448-453

74. Paoletti AM, Cagnacci
A, Orru M, Ajossa S, Guerriero S, Melis

GB. Treatment with
flutamide improves hyperinsulinemia in

women with idiopathic
hirsutism. Fertil Steril 1999 72:448-453

75. Paulson RJ, Serafini PC,
Catalino JA, Lobo RA. Measurements

of 3a, 17 b-androstanediol
glucuronide in serum and urine

and the correlation with
skin 5a-reductase activity. Fertil

Steril 1996 46:222-226

76. Philpott MP, Sanders
DA, Kealey T. Effects of insulin and

insulin-like growth
factors on cultured human hair follicles:

IGF-1 at physiologic
concentrations is an important regulator of

hair follicle growth in
vitro. J Invest Dermatol 1994 102:857-861

77. Pittaway DE, Maxson
WS, Wentz AC. Spironolactone in

combination drug therapy
for unresponsive hirsutism. Fertil

Steril 1985 43: 878-882

78. Pugeat M, Forest M,
Nisula B, Corniau, De Pere t t i ,

Tourniaire. Evidence of
excessive androgen secretion by

both the ovary and the
adrenal in patients with idiopathic

hirsutism. Obstet Gynecol
1982 59:46-51

79. Randall VA. Androgens
and human hair growth. Clin

Endocrinol 1994 (Oxf)
40:439-457

80. Rittmaster RS,
Thompson DL. Effect of leuprolide and

dexamethasone on hair
growth and hormone levels in

hirsute women: the
relative importance of the ovary and the

adrenal in the
pathogenesis of hirsutism. J Clin Endocrinol

Metab 1990 70:1096-1102

81. Rittmaster RS.
Androgen conjugates: physiology and clinical

significance. Endocr Rev
1993 14:121-132

82. Rittmaster RS.
Finasteride. N Engl J
Med 1994 330:120-125

83. San Millan JL, Sancho J,
Calvo RM. Role of
pentanucleotide

(TTTTA) polymorphism in
the promoter of the CYP11 gene

in the pathogenesis of
hirsutism. Fertil Steril 2001 75(4):797-802

84. Sawaya ME, Price VH.
Different levels of 5 a-reductase type

I and II, aromatase, and
androgen receptor in hair follicles

of women and men with androgenetic
alopecia. J Invest

Dermatol 1997 109:296-300

85. Sawaya ME, Shalita AR.
Androgen receptor polymorphisms

(CAG repeat lengths) in
androgenetic alopecia, hirsutism

and acne. J Cutan Med Surg
1998 3:9-15

86. Serafini P, Lobo RA.
Increased 5a-reductase activity in

idiopathic hirsutism.
Fertil Steril 1985 43:74-78

87. Serafini P, Lobo RA.
The effects of spironolactone on adre n a l

s t e roidogenesis in
hirsute women. Fertil Steril 1985 44:595-599

88. Stenn, Paus, Filippi.
Letter to the Editor. J Invest Dermatol

1998 110:95

8 9 . Tartagni M, Schonauer L, De
Salvia M, Cicinelli E, De

P e rgola G, D"Addario V.
Comparison of Diane 35 and

Diane 35 plus finasteride
in the treatment of hirsutism 2000

7 3 ( 4 ) : 7 1 8 – 7 2 3

90. Thigpen AE, Silver RI,
Guilleyard JM, Casey ML, McConnell

JD, Russell DW. Tissue
distribution and ontogeny of steroid

5-reductase isoenzyme
expression. J Clin Invest 1993 92:903-

910

91. Thomas JP, Oake RJ.
Androgen metabolism in the skin of

hirsute women. J Clin
Endocrinol Metab 1974 38:19-22

92. Tolino A, Petrone A,
Sarnacchiaro F, Cirillo D, Ronsini S,

Lombardi G, Nappi C.
Finasteride in the treatment of

hirsutism: new therapeutic
perspectives. Fertil Steril 1996 66:61-65

93. Venturoli S,
Marescalchi O, Colombo FM, Macrelli S, Ravaioli

B, Bagnoli A, Paradisi R,
Flamigni C. A pro s p e c t i v e

randomized trial comparing
low dose flutamide, finasteride,

ketoconazole, and
cyproterone acetate-estrogen regimens in the treatment of hirsutism. J Clin
Endocrinol Metab 1999 84:1304-1310

94. Vermeulen A, Stoica T,
Verdonck L. The apparent free testosterone concentration, an index of
androgenicity. J Clin

Endocrinol 1971 33:759-767

95. Vottero A, Stratakis
C, Ghizzoni L, Longui C, Karl M, Chrousos G. Androgen Receptor-Mediated
Hypersensitivity

to Androgens in Women with
Nonhyperandro g e n i c

Hirsutism: Skewing of
X-Chromosome Inactivation. J Clin Endocrinol Metab 1999 84(3):1091-1095

96. Wahe M, Antonipillai
I, Horton R. Effects of transforming growth factor band epidermal growth factor
on steroid 5areductase activity in genital skin fibroblasts. Mol Cell Endocrinol
1993 98: 55-59 97. Wilson J 1996 Androgens. In: Gilman AG, Rall TW, Nies AS, Taylor
P (ed) Goodman and Gilman"s The Pharmacological Basis of Therapeutics, ed 9.
McGraw Hill Publishers, New York, pp 1441-1457

98. Wudy S, Wachter U,
Homoki J, Teller W. 5 alpha-androstane- 3 alpha, 17 beta-diol and 5
alpha-andostane-3 alpha, 17 beta-diol-glucuronede in plasma of anormal
children, adults and patients with idiopathic hirsutism: a mass spectrometric study.
Eur J Endocrinol 1996 134(1):87-92

99. Young RL, Goldzieher
JW, Elkind-Hirsch K. The endocrine effects of spironolactone used as an
antiandrogen. Fertil

Steril 1987 48: 223-228

ANEXOS

DESARROLLO DEL PELO

Figura 1. Desarrollo del pelo

 

Figura 2. Formación total del folículo
piloso y formación del pelo

            ALTERACIONES DEL PELO

hair_05

Figura 3. Niño con Alopecia

123a047ninag

Figura 4. Niña con Hipertricosis

 

Figura 6. Alteración
del folículo piloso: Tricoepitelioma múltiple (epitelioma adenoide
quístico)

 

Figura 7. Alopecia
andrógena: Fases de calvice.

 

 

 

 

 

Autor:

Villegas Huam?n, Yenner Antonio

javh5[arroba]hotmail.com

DOCENTES:

Dr.
?lvarez Carrillo Javier

Dr.
Cruzalegui Henr?quez Rodil

Dr.
Flori?n Zavaleta Luis

Dr.
Fonseca Guillermo

?REA:
Embriolog?a M?dica

UNIVERSIDAD
NACIONAL DE TRUJILLO

FACULTAD DE
MEDICINA

ESCUELA DE
MEDICINA

DEPARTAMENTO
DE MORFOLOG?A

FECHA: 21/07/08

Partes: 1, 2, 3, 4, 5
 Página anterior Volver al principio del trabajoPágina siguiente 

Nota al lector: es posible que esta página no contenga todos los componentes del trabajo original (pies de página, avanzadas formulas matemáticas, esquemas o tablas complejas, etc.). Recuerde que para ver el trabajo en su versión original completa, puede descargarlo desde el menú superior.

Todos los documentos disponibles en este sitio expresan los puntos de vista de sus respectivos autores y no de Monografias.com. El objetivo de Monografias.com es poner el conocimiento a disposición de toda su comunidad. Queda bajo la responsabilidad de cada lector el eventual uso que se le de a esta información. Asimismo, es obligatoria la cita del autor del contenido y de Monografias.com como fuentes de información.

Categorias
Newsletter